Clinical Trial Detail

NCT ID NCT03541369
Title Safety, Tolerability, PK, PD, and Efficacy of AMG 427 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (20170528)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amgen
Indications

acute myeloid leukemia

Therapies

AMG 427

Age Groups: adult senior

No variant requirements are available.